These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12609221)

  • 21. Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types.
    Fang Y; Wu X; Xu L; Tang X; Wang J; Zhu G; Hong Z
    J Clin Neurosci; 2014 Jan; 21(1):55-62. PubMed ID: 24231559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which should be the first-line drug for newly diagnosed epilepsy? Commentary on the SANAD study.
    Neligan A; Shorvon SD
    Pol Arch Med Wewn; 2008; 118(1-2):11-3. PubMed ID: 18405167
    [No Abstract]   [Full Text] [Related]  

  • 23. Confusing placebo effect with natural history in epilepsy: A big data approach.
    Goldenholz DM; Moss R; Scott J; Auh S; Theodore WH
    Ann Neurol; 2015 Sep; 78(3):329-36. PubMed ID: 26150090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnitude and pattern of placebo response in clinical trials of antiepileptic medications: Data from the Food and Drug Administration 1996-2016.
    Khan A; Fahl Mar K; Schilling J; Brown WA
    Contemp Clin Trials; 2018 Jan; 64():95-100. PubMed ID: 29101042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-choice drug for newly diagnosed epilepsy.
    French JA
    Lancet; 2007 Mar; 369(9566):970-1. PubMed ID: 17382806
    [No Abstract]   [Full Text] [Related]  

  • 26. Social factors associated with treating epilepsy in the elderly.
    Rowan AJ
    Geriatrics; 2005 May; Suppl():16-9. PubMed ID: 16025884
    [No Abstract]   [Full Text] [Related]  

  • 27. Rufinamide: a new anti-epileptic medication.
    Hakimian S; Cheng-Hakimian A; Anderson GD; Miller JW
    Expert Opin Pharmacother; 2007 Aug; 8(12):1931-40. PubMed ID: 17696794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy.
    Ben-Menachem E; Sander JW; Stefan H; Schwalen S; Schäuble B
    Clin Ther; 2008 Jul; 30(7):1180-95. PubMed ID: 18691980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiepileptic drugs, clinical trials, and the marketplace.
    Brodie MJ
    Lancet; 1996 Mar; 347(9004):777-9. PubMed ID: 8622329
    [No Abstract]   [Full Text] [Related]  

  • 30. Melatonin as add-on treatment for epilepsy.
    Brigo F; Del Felice A
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006967. PubMed ID: 22696363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What trials, which designs?
    French JA
    Epilepsia; 1997 Mar; 38(3):263-5. PubMed ID: 9070585
    [No Abstract]   [Full Text] [Related]  

  • 32. Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it.
    Schulze-Bonhage A; Elger CE
    Epilepsia; 1997 Oct; 38(10):1155. PubMed ID: 9579964
    [No Abstract]   [Full Text] [Related]  

  • 33. Review of new antiepileptic drugs (AEDs).
    Cramer JA; Mattson RH; Scheyer RD; French J
    Epilepsia; 1998 Feb; 39(2):233-4. PubMed ID: 9578005
    [No Abstract]   [Full Text] [Related]  

  • 34. Is there a place for placebo controlled trials of antiepileptic drugs?
    Shorvon SD; Espir ML; Steiner TJ; Dellaportas CI; Rose FC
    Br Med J (Clin Res Ed); 1985 Nov; 291(6505):1328-9. PubMed ID: 3933653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Many options for epilepsy: comparisons of first- and second-generation AEDs.
    Bazil CW
    Curr Neurol Neurosci Rep; 2008 Jul; 8(4):323-4. PubMed ID: 18590616
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecule of the month. Lacosamide.
    Drug News Perspect; 2004 Dec; 17(10):689. PubMed ID: 15696232
    [No Abstract]   [Full Text] [Related]  

  • 37. Are cannabinoids effective for epilepsy?
    Peña J; Rada G
    Medwave; 2017 Jan; 17(Suppl1):e6821. PubMed ID: 28112710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials.
    Tomson T; Hirsch LJ; Friedman D; Bester N; Hammer A; Irizarry M; Ishihara L; Krishen A; Spaulding T; Wamil A; Leadbetter R
    Epilepsia; 2013 Jan; 54(1):135-40. PubMed ID: 23030403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active control trials for epilepsy: avoiding bias in head-to-head trials.
    French JA; Kryscio RJ
    Neurology; 2006 May; 66(9):1294-5. PubMed ID: 16682655
    [No Abstract]   [Full Text] [Related]  

  • 40. Protocol design.
    Wilensky AJ
    Epilepsy Res Suppl; 1993; 10():107-13. PubMed ID: 8251086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.